Skip to main content
. 2024 Aug 19;47(12):1203–1224. doi: 10.1007/s40264-024-01470-0

Fig. 3.

Fig. 3

Graphical summary of the incidence of individuals with at least one AE assessed for each primary study. AE adverse events, CI confidence interval, HBV hepatitis B virus, HCV hepatitis C virus, HIV human immunodeficiency virus